Zim Laboratories peers

Companies like Zim Laboratorieslatest year

Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

ZIMLAB₹141.26

Zim Laboratories Limited

· Pharma & Health
₹ CrorePeersANUHPHRVALIANTLABAHCLALBERTDAVDWANBURYHALEOSLABSBAJAJHCARETHEMISMEDMcap ₹756 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
ZIMLAB
FY26
ANUHPHR
FY26
VALIANTLAB
FY26
AHCL
FY26
Peer
Average
Valuation — at last close
P/E118.71×19.42×—◆ 4.00×11.71× +914%
P/B2.55×2.27×2.20×◆ 0.56×1.68× +52%
EV/EBITDA27.83×12.07×108.79×◆ 4.08×41.64× -33%
Market Cap₹756 Cr₹798 Cr₹683 Cr₹130 Cr₹537 Cr +41%
Growth
Revenue CAGR 3Y-2.06%————
Net Income CAGR 3Y-37.95%————
Revenue YoY (latest Q)31.25%3.93%◆ 146.22%—75.08% -58%
Net Income YoY (latest Q)-114.25%37.63%◆ 1058.93%—548.28% -121%
Profitability
EBITDA Margin8.02%8.00%2.69%◆ 27.63%12.77% -37%
Net Income Margin1.56%5.32%-1.38%◆ 16.92%6.95% -78%
Return on Common Equity2.13%12.10%-1.20%◆ 12.38%7.76% -73%
Return on Capital Employed3.06%14.75%0.10%◆ 17.26%10.70% -71%
Return on Assets1.15%7.72%-0.76%◆ 7.78%4.91% -77%
Credit & Quality
Total Debt/Equity0.42×◆ 0.00×0.14×0.17×0.10× +306%
Interest Coverage0.76×◆ 106.58×0.18×12.30×39.69× -98%
Scale — latest FY
Revenue / Total Income₹374 Cr₹772 Cr₹237 Cr₹172 Cr₹394 Cr -5%
Net Income₹5.8 Cr₹41 Cr−₹3.3 Cr₹29.1 Cr₹22.3 Cr -74%
Total Assets₹539 Cr₹557 Cr₹464 Cr₹374 Cr₹465 Cr +16%
EPS₹1.19₹4.1₹-0.51₹6.11₹3.23 -63%
Book Value per Share₹55.36₹35.14₹57.24₹43.32₹45.23 +22%
◆ best value in the comp set per metric · Δ = subject vs average of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.